FDA Inspection 1277176 — IDT Biologika GmbH

IDT Biologika GmbH — FEI 3005001757

The FDA completed an inspection of IDT Biologika GmbH on Aug 25, 2023 in Dessau-Rosslau. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 25, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dessau-Rosslau (Germany)

Additional details

Mutual Recognition Agreement (MRA)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.